Acquired von Willebrand's disease: A concise review

American Journal of Hematology

Volumn 54, Issue 2, 1997, Pages 139-145

  Rinder, Morton R ^a   Richard, Robert E ^a   Rinder, Henry M ^b  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acquired; inhibitor; pathophysiology; therapy; von Willebrand's disease

Indexed keywords

IMMUNOGLOBULIN G; VON WILLEBRAND FACTOR;

ADULT; BLEEDING; CASE REPORT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VON WILLEBRAND DISEASE;

ANTIBODIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

EID: 0031042922     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199702)54:2<139::AID-AJH7>3.0.CO;2-Y     Document Type: Review

References (60)

1. Jakaway JL: Acquired von Willebrand's disease in malignancy. Semin Thromb Hemost 18:434, 1992.
2. Jakaway JL: Acquired von Willebrand's disease. Hematol Oncol Clin North Am 6:1409, 1992.
3. Cooney KA, Ginsburg D, Ruggeri ZM: von Willebrand disease. In Loscalzo J, Schafer AI (eds): "Thrombosis and Hemorrhage" Boston: Blackwell Scientific Publications, Inc., p 657, 1994.
4. Handin RI, Martin V, Moloney WC: Antibody induced von Willebrand's disease: a newly defined inhibitor syndrome. Blood 483: 393, 1976.
5. Takahashi H, Nagayama R, Tanabe Y, Satoh K, Hanano M, Mito M, Shibata A: DDAVP in acquired von Willebrand syndrome associated with multiple myeloma. Am J Hematol 22:421, 1986.
6. Tran-Thang C, Mannucci PM, Schneider PH, Federici A, Bachman F: Profound alterations of the multimeric structure of von Willebrand's factor in a patient with malignant lymphoma. Br J Haematol 61:307, 1985.
7. Jehlinger J, Rose E, Aledort LM: Successful treatment of an acquired von Willebrand's factor antibody to extracorporeal immunoadsorption. N Engl J Med 320:254, 1989.
8. Van Genederen PJJ, Michiels JJ, Bakker JJ, Van't Veer MB: Effective- ness of high-dose intravenous gamma globulin therapy in acquired von Willebrand's disease. Vox Sang 67:14, 1944.
9. Rao KPP, Kizer J, Jones TJ, Anunciado A, Pepkowitz Sh, Lazarchick J: Acquired von Willebrand's syndrome associated with an extranodal pulmonary lymphoma. Arch Pathol Lab Med 112:47, 1988.
10. Van Genderen PJJ, Vink T, Michiels JJ, Van't Veer MB, Sixma JJ, Van Vilet HHDM: Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen. Blood 84:3378, 1994.
11. Van Genderen PJJ, Papatsonis NM, Michiels JJ, Wielenga JJ, Stibbe J, Huikeshoven JM: High-dose intravenous gammaglobulin therapy for acquired von Willebrand disease. Postgrad Med J 70:916, 1994.
12. Bovill EG, Ershler WB, Golden EA, Tindle BH, Edson JR: A human myeloma-produced monoclonal protein directed against the active sub-population of von Willebrand factor. Am J Clin Pathol 85:115, 1986.
13. Brownlee RE, Shockley WW: Acquired von Willebrand's syndrome. Arch Otolaryngol Head Neck Surg 117:106, 1991.
14. Richard C, Cuadrado MA, Prieto M, Batlle H, Lopez-Fernandez L, Rodrieguez Salazar ML, Recio M, Santoro T, Gomez Casares MT, Zubizarreta A: Acquired von Willebrand disease in multiple myeloma secondary to absorption of von Willebrand factor by plasma cells. Am J Hematol 35:114, 1990.
15. Roussi JH, Houbouyan LL, Alterescu R, Franc B, Goguel AF: Acquired von Willebrand's syndrome associated with hairy cell leukaemia. Br J Haematol 46:503, 1980.
16. Sampson BM, Greaves M, Malia RG, Preston FE: Acquired von Willebrand's disease: Demonstration of a circulating inhibitor to the factor VIII complex in four cases. Br J Haematol 54:233, 1983.
17. Mohri H, Noguchi T, Kodama F, Itoh A, Ohkuba T: Acquired von Willebrand's disease due to inhibitor of human myeloma protein specific for von Willebrand factor. Am J Clin Pathol 87:663, 1987.
18. Mannucci PM, Lombardi R, Bader R, Horellou MH, Finazzi G, Conard J, Samama M: Studies of the pathophysiology of acquired von Willebrand's disease in seven patients with lymphoproliferative disorders or benign monoclonal gammopathies. Blood 64:614, 1984.
19. Gross S, Traulle C, Capiod JC, Roussel B, Lafon B, Hayek E, Dieval J, Delobel J: Efficacy of high-dose intravenous gammaglobulin in the management of acquired von Willebrand's disease during orthopaedic surgery. Br J Haematol 82:170, 1992.
20. Arkel YS, Lynch J, Kamiyama M: Treatment of acquired von Willebrand's syndrome with intravenous immunoglobulin. Thromb Haemost 72:643, 1994.
21. Castaman G, Tosetto A, Rodeghiero F: Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand's syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate. Am J Hematol 41:132, 1992.
22. Delannoy A, Saillez AC: High-dose intravenous gammaglobulin for acquired von Willebrand's disease. Br J Haematol 70:387, 1988.
23. Delmer A, Horellou MH, Brechot JM, Prudent J, Potevin F, Lecrubier C, Girard-Longhini C, Samama M, Zittoun R: Acquired von Willebrand's disease: Correction of hemostatic defect by high-dose intravenous immunoglobulins. Am J Hematol 40:151, 1992.
24. Eng Gan T, Sawers RJ, Koutts J: Pathogenesis of antibody-induced acquired von Willebrand's syndrome. Am J Hematol 9:363, 1980.
25. Fricke WA, Brinkhous KM, Garris JB, Roberts HR: Comparison of inhibitory and binding characteristics of an antibody causing acquired von Willebrand's syndrome: An assay for von Willebrand factor binding antibody. Blood 66:562, 1985.
26. Gralnick HR, Flaum MA, Kessler CM, Zimbler H, Coller BS: IgA inhibitor to factor VIII/von Willebrand factor. Br J Haematol 59:149, 1985.
27. Macik BG, Gabriel DA, White GC, High K, Roberts H: The use of high-dose intravenous γ-globulin in acquired von Willebrand's syndrome. Arch Pathol Lab Med 112:143, 1988.
28. Meyer D, Frommel D, Larrieu MJ, Zimmerman TS: Selective absence of large forms of factor VII/von Willebrand's factor in acquired von Willebrand's syndrome. Response to transfusion. Blood 54:600, 1979.
29. Scrobohaci ML, Daniel MT, Levy T, Marolleau JP, Brouet JC: Expression of gpIb on plasma cells in a patient with monoclonal IgG and acquired von Willebrand's disease. Br J Haematol 84:471, 1993.
30. White L, Chisholm M: Gastro-intestinal bleeding in acquired von Willebrand's disease: Efficacy of high-dose immunoglobulin where substitution treatments failed. Br J Haematol 84:332, 1993.
31. Zettervall O, Nilsson IM: Acquired von Willebrand's disease caused by a monoclonal antibody. Acta Med Scand 204:521, 1978.
32. Wautier JL, Levy-Toledano S, Caen JP: Acquired von Willebrand's syndrome and thrombopathy in a patient with chronic lymphocytic leukaemia. Scand J Haematol 16:128, 1976.
33. Budde U, Schaefer G, Mueller N, Egli H, Dent J, Ruggeri Z, Zimmerman T: Acquired von Willebrand's disease in the myeloproliferative syndrome. Blood 64:981, 1984.
34. Van Genderen PJJ, Michiels JJ, Van der Poel-van de Luytgaarde SCPAM, Van Vliet HHDM: Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: Relationship with platelet count. Ann Hematol 69:81, 1994.
35. Lazarchick H, Pappas AA, Kizer J, Hall SA: Acquired von Willebrand syndrome due to an inhibitor specific for von Willebrand factor antigens. Am J Hematol 21:305, 1986.
36. Murakawa M, Okamura T, Tsutsumi K, Tanoguchi S, Kamura T, Shibuya T, Harada M, Niho Y: Acquired von Willebrand's disease in association with essential thrombocythemia: Regression following treatment. Acta Haematol (Basel) 87:83, 1992.
37. Carter C, Boughton BJ: Acquired von Willebrand's disease in myelo-proliferative syndrome: Spontaneous remission during pregnancy. Thromb Haemost 67:387, 1992.
38. Simone JV, Cornet JA, Abilgaard CF: Acquired von Willebrand's syndrome in systemic lupus erythematosus. Blood 31:806, 1968.
39. Bruggers CS, McElliogott K, Rallison ML: Acquired von Willebrand disease in twins with autoimmune hypothyroidism: Response to desmopressin and L-thyroxine therapy. J Pediatr 125:911, 1994.
40. Pizzuto J, Ambriz R, De la Paz Reyna M, Monrroy LM, Morales MR, Aviles A, Conte G, Enriquez R: Acquired von Willebrand's syndrome during autoimmune disorder. Thromb Haemost 42:1523, 1980.
41. Poole-Wilson PA: Acquired von Willebrand's syndrome and systemic lupus erythematosus. Proc Soc Med 65:7, 1972.
42. Hanley D, Arkel YS, Lynch J, Kamiyama M: Acquired von Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin. Am J Hematol 46:141, 1994.
43. Coccia MR, Barnes HV: Hypothyroidism and acquired von Willebrand disease. J Adolesc Health 12:152, 1991.
44. Castaman G, Lattuada A, Mannucci PM, Rodeghiero F: Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: Evidence for heightened proteolysis of von Willebrand factor. Am J Hematol 49:83, 1995.
45. Castaman G, Rodeghiero F: Acquired transitory von Willebrand syndrome with ciprofloxacin. Lancet 343:492, 1994.
46. Conrad ME, Latour LF: Acquired von Willebrand's disease, IgE polyclonal gammopathy, and griseofulvin therapy. Am J Hematol 41:2, 1992.
47. Kreuz W, Linde R, Funk M, Meyer-Schrod R, Foil E, Nowak-Gottl U, Jacobi G, Vigh Z, Scharrer I: Induction of von Willebrand disease type I by valproic acid. Lancet 335:1350, 1990.
48. Dalrymple-Hay M, Aitchison R, Collins P, Sekhar M, Colvin B: Hydroxyethyl starch induced acquired von Willebrand's disease. Clin Lab Haematol 14:209, 1992.
49. Eikenboom JCJ, Van Der Meer FJM, Briet E: Acquired von Willebrand's disease due to excessive fibrinolysis. Br J Haematol 81:618, 1992.
50. Federici AB, Berkowitz SD, Zimmerman TS, Mannucci PM: Proteolysis of von Willebrand factor after thrombolytic therapy in patients with acute myocardial infarction. Blood 79:38, 1992.
51. Coppes MJ, Zandvoort SWH, Sparling CR, Poon AO, Wetizman S, Blanchette VS: Acquired von Willebrand disease in Wilm's tumor patients. J Clin Oncol 10:422, 1992.
52. Facon T, Caron C, Courtin P, Wurtz A, Deghaye M, Bauters F, Mazurier C, Goudemand J: Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma. Br J Haematol 80:488, 1992.
53. Scott JP, Montgomery RR, Tubergan DG, Hays T: Acquired von Willebrand's disease associated with Wilm's tumor: Regression following treatment. Blood 58:665, 1981.
54. Lazarchick J, Green C: Acquired von Willebrand's disease following bone marrow transplantation. Ann Clin Lab Sci 24:211, 1994.
55. Weiss HJ, Hawiger J, Ruggeri ZM, Turitto VT, Thiagarajan P, Hoffmann T: Fibrinogen-independent platelet adhesion and thrombus formation on subendothelium mediated by GPIIb/IIIa complex at high shear rate. J Clin Invest 83:288, 1989.
56. Plow EF, Pierschbacher MD, Ruoslahti E, Marguerie GA, Ginsberg MH: The effect of arg-gly-asp containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci USA 82:8057, 1985.
57. Bockenstedt PL: Laboratory methods in hemostasis. In Loscalzo J, Schafer AI (eds): "Thrombosis and Hemorrhage" Boston: Blackwell Scientific Publications, Inc., p 445, 1994.
58. Holland L, Adamson A, Ingram GIC, Chalmers DG: Acquired von Willebrand's syndrome. Br J Haematol 45:161, 1980.
59. Alexanian R, Dimoupoulos MA, Delasalle K, Barlogie B: Primary dexamethasone treatment of multiple myeloma. Blood 80:887, 1992.
60. Dimoupoulos MA, Alexanian R: Waldenstrom's macroglobulinemia. Blood 83: 1452, 1994.